Prod.No. |
Product Name |
Size |
RMB 目录价 |
Effective: 09-May-11 |
|
|
|
ALX-101-003-G001 |
beta-Alanine |
1 g |
149 |
ALX-101-004-G025 |
L-Arginine |
25 g |
149 |
ALX-101-005-G005 |
D-Arginine |
5 g |
560 |
ALX-101-010-G001 |
L-Aspartic acid |
1 g |
112 |
ALX-101-011-G001 |
D-Aspartic acid |
1 g |
112 |
ALX-101-012-G010 |
L-Cysteine . hydrochloride |
10 g |
355 |
ALX-101-016-G005 |
L-Glutamine |
5 g |
112 |
ALX-101-017-G001 |
D-Glutamine |
1 g |
299 |
ALX-101-036-G005 |
L-Ornithine . hydrochloride |
5 g |
112 |
ALX-101-036-G025 |
L-Ornithine . hydrochloride |
25 g |
261 |
ALX-101-037-G001 |
D-Ornithine . hydrochloride |
1 g |
149 |
ALX-101-037-G005 |
D-Ornithine . hydrochloride |
5 g |
560 |
ALX-101-051-G001 |
L-Tryptophan |
1 g |
112 |
ALX-101-057-G010 |
L-Histidine . hydrochloride . monohydrate |
10 g |
112 |
ALX-101-058-G001 |
D-Histidine . hydrochloride . monohydrate |
1 g |
131 |
ALX-105-001-G005 |
NG-Nitro-L-arginine |
5 g |
205 |
ALX-105-001-G025 |
NG-Nitro-L-arginine |
25 g |
579 |
ALX-105-002-M250 |
NG-Nitro-D-arginine |
250 mg |
205 |
ALX-105-002-G001 |
NG-Nitro-D-arginine |
1 g |
485 |
ALX-105-003-G005 |
L-NAME . hydrochloride |
5 g |
877 |
ALX-105-003-G025 |
L-NAME . hydrochloride |
25 g |
3472 |
ALX-105-004-M250 |
D-NAME . hydrochloride |
250 mg |
299 |
ALX-105-005-G001 |
N-Acetyl-L-cysteine |
1 g |
224 |
ALX-105-005-G005 |
N-Acetyl-L-cysteine |
5 g |
373 |
ALX-105-009-M010 |
N-Methyl-D-aspartic acid |
10 mg |
205 |
ALX-105-009-M050 |
N-Methyl-D-aspartic acid |
50 mg |
541 |
ALX-105-010-M010 |
N-Methyl-L-aspartic acid |
10 mg |
187 |
ALX-105-010-M050 |
N-Methyl-L-aspartic acid |
50 mg |
467 |
ALX-105-011-M100 |
S-Trityl-L-cysteine |
100 mg |
187 |
ALX-105-011-M500 |
S-Trityl-L-cysteine |
500 mg |
541 |
ALX-106-001-M005 |
L-NMMA . monoacetate |
5 mg |
261 |
ALX-106-001-M025 |
L-NMMA . monoacetate |
25 mg |
803 |
ALX-106-001-M100 |
L-NMMA . monoacetate |
100 mg |
2613 |
ALX-106-001-G001 |
L-NMMA . monoacetate |
1 g |
4125 |
ALX-106-002-M005 |
D-NMMA . monoacetate |
5 mg |
392 |
ALX-106-002-M025 |
D-NMMA . monoacetate |
25 mg |
1325 |
ALX-106-002-M100 |
D-NMMA . monoacetate |
100 mg |
4051 |
ALX-106-003-G005 |
L-Citrulline |
5 g |
187 |
ALX-106-004-M005 |
NG-Hydroxy-L-arginine . monoacetate |
5 mg |
1027 |
ALX-106-004-M025 |
NG-Hydroxy-L-arginine . monoacetate |
25 mg |
4051 |
ALX-106-005-M005 |
NG, NG-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) |
5 mg |
205 |
ALX-106-005-M025 |
NG, NG-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) |
25 mg |
504 |
ALX-106-006-M005 |
NG, NG-Dimethyl-L-arginine . dihydrochloride |
5 mg |
448 |
ALX-106-006-M025 |
NG, NG-Dimethyl-L-arginine . dihydrochloride |
25 mg |
1232 |
ALX-106-007-M005 |
NG, N'G-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) |
5 mg |
205 |
ALX-106-007-M025 |
NG, N'G-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) |
25 mg |
504 |
ALX-106-008-M005 |
NG, N'G-Dimethyl-L-arginine . dihydrochloride |
5 mg |
448 |
ALX-106-008-M025 |
NG, N'G-Dimethyl-L-arginine . dihydrochloride |
25 mg |
1139 |
ALX-106-010-M005 |
NG-Monoethyl-L-arginine . monoacetate |
5 mg |
411 |
ALX-106-010-M025 |
NG-Monoethyl-L-arginine . monoacetate |
25 mg |
1605 |
ALX-106-011-M005 |
NG-Monomethyl-L-homoarginine . monoacetate |
5 mg |
280 |
ALX-106-011-M025 |
NG-Monomethyl-L-homoarginine . monoacetate |
25 mg |
1101 |
ALX-106-012-M010 |
S-Methyl-L-thiocitrulline . dihydrochloride |
10 mg |
597 |
ALX-106-012-M050 |
S-Methyl-L-thiocitrulline . dihydrochloride |
50 mg |
1997 |
ALX-106-013-M010 |
L-Thiocitrulline . dihydrochloride |
10 mg |
728 |
ALX-106-013-M050 |
L-Thiocitrulline . dihydrochloride |
50 mg |
2893 |
ALX-106-014-M005 |
NG-Amino-L-arginine . hydrochloride |
5 mg |
672 |
ALX-106-015-G001 |
L-allo-Isoleucine |
1 g |
1008 |
ALX-106-020-G005 |
3-Nitro-L-tyrosine |
5 g |
821 |
ALX-106-020-G001 |
3-Nitro-L-tyrosine |
1 g |
224 |
ALX-106-023-M500 |
5-Hydroxy-L-tryptophan |
500 mg |
187 |
ALX-106-024-G001 |
O-Phospho-L-serine |
1 g |
149 |
ALX-106-025-G010 |
gamma-Aminobutyric acid |
10 g |
75 |
ALX-106-026-M050 |
L-alpha-Aminoadipic acid |
50 mg |
93 |
ALX-106-026-M250 |
L-alpha-Aminoadipic acid |
250 mg |
280 |
ALX-106-027-M050 |
D-alpha-Aminoadipic acid |
50 mg |
187 |
ALX-106-027-M250 |
D-alpha-Aminoadipic acid |
250 mg |
653 |
ALX-106-028-M050 |
D-Cycloserine |
50 mg |
187 |
ALX-106-028-M250 |
D-Cycloserine |
250 mg |
728 |
ALX-106-030-G001 |
p-Chloro-DL-phenylalanine |
1 g |
149 |
ALX-106-031-M050 |
p-Chloro-L-phenylalanine |
50 mg |
149 |
ALX-106-031-M250 |
p-Chloro-L-phenylalanine |
250 mg |
411 |
ALX-106-037-M025 |
L-Cycloserine |
25 mg |
373 |
ALX-106-037-M100 |
L-Cycloserine |
100 mg |
1157 |
ALX-106-040-M050 |
1-Methyl-L-tryptophan |
50 mg |
299 |
ALX-106-041-M050 |
1-Methyl-D-tryptophan |
50 mg |
373 |
ALX-106-042-G001 |
L-Theanine |
1 g |
429 |
ALX-106-042-G005 |
L-Theanine |
5 g |
1736 |
ALX-106-042-G025 |
L-Theanine |
25 g |
6067 |
ALX-121-002-G100 |
TBTU |
100 g |
2819 |
ALX-121-002-G250 |
TBTU |
250 g |
5637 |
ALX-121-002-G500 |
TBTU |
500 g |
9837 |
ALX-121-003-G100 |
HBTU |
100 g |
3752 |
ALX-121-003-G250 |
HBTU |
250 g |
7653 |
ALX-121-003-G500 |
HBTU |
500 g |
12768 |
ALX-151-002-PC05 |
beta-Amyloid (1-42) |
0.5 mg* |
5059 |
ALX-151-002-P001 |
beta-Amyloid (1-42) |
1 mg* |
8251 |
ALX-151-003-PC05 |
beta-Amyloid (1-40) |
0.5 mg* |
4181 |
ALX-151-003-P001 |
beta-Amyloid (1-40) |
1 mg* |
7448 |
ALX-151-005-PC05 |
beta-Amyloid (1-28) |
0.5 mg* |
1456 |
ALX-151-005-P001 |
beta-Amyloid (1-28) |
1 mg* |
2464 |
ALX-151-008-P001 |
beta-Amyloid (25-35) |
1 mg* |
1101 |
ALX-151-008-P005 |
beta-Amyloid (25-35) |
5 mg* |
4368 |
ALX-151-011-P001 |
beta-Amyloid/A4 Protein Precursor [APP] (328-332) |
1 mg* |
821 |
ALX-151-011-P005 |
beta-Amyloid/A4 Protein Precursor [APP] (328-332) |
5 mg* |
3285 |
ALX-151-013-MC05 |
Apamin |
0.5 mg |
1456 |
ALX-151-014-MC05 |
cAMP-dependent Protein Kinase Inhibitor (5-24) |
0.5 mg |
821 |
ALX-151-014-M001 |
cAMP-dependent Protein Kinase Inhibitor (5-24) |
1 mg |
1456 |
ALX-151-016-MC05 |
cAMP-dependent Protein Kinase Inhibitor (5-22) amide |
0.5 mg |
1008 |
ALX-151-016-M001 |
cAMP-dependent Protein Kinase Inhibitor (5-22) amide |
1 mg |
1643 |
ALX-151-018-MC05 |
cAMP-dependent Protein Kinase Inhibitor (5-24) amide |
0.5 mg |
821 |
ALX-151-018-M001 |
cAMP-dependent Protein Kinase Inhibitor (5-24) amide |
1 mg |
1456 |
ALX-151-019-MC05 |
cAMP-dependent Protein Kinase Substrate |
0.5 mg |
877 |
ALX-151-019-M001 |
cAMP-dependent Protein Kinase Substrate |
1 mg |
1493 |
ALX-151-020-M010 |
N-Acetyl-Asp-Glu-OH |
10 mg |
317 |
ALX-151-020-M050 |
N-Acetyl-Asp-Glu-OH |
50 mg |
1269 |
ALX-151-021-M001 |
H-Arg-Gly-Tyr-Ser-Leu-Gly-OH |
1 mg |
373 |
ALX-151-021-M005 |
H-Arg-Gly-Tyr-Ser-Leu-Gly-OH |
5 mg |
1269 |
ALX-151-024-M001 |
H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH |
1 mg |
877 |
ALX-151-024-M005 |
H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH |
5 mg |
5992 |
ALX-151-026-M001 |
N-Acetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 |
1 mg |
821 |
ALX-151-027-M001 |
N-Acetyl-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 |
1 mg |
821 |
ALX-151-029-M001 |
Autocamtide-2-Related Inhibitory Peptide |
1 mg |
1101 |
ALX-151-029-M005 |
Autocamtide-2-Related Inhibitory Peptide |
5 mg |
4331 |
ALX-151-030-MC05 |
Autocamtide-2-Related Inhibitory Peptide (Myristoylated) |
0.5 mg |
1307 |
ALX-151-031-M001 |
Caspase-3 Control Peptide |
1 mg |
317 |
ALX-151-035-M001 |
Ac-muramyl-Ala-D-Glu-amide |
1 mg |
597 |
ALX-151-035-M005 |
Ac-muramyl-Ala-D-Glu-amide |
5 mg |
1867 |
ALX-151-036-M001 |
Ac-muramyl-D-Ala-D-Glu-amide |
1 mg |
1064 |
ALX-151-036-M005 |
Ac-muramyl-D-Ala-D-Glu-amide |
5 mg |
4629 |
ALX-151-037-M005 |
Angiotensin I |
5 mg |
373 |
ALX-151-037-M025 |
Angiotensin I |
25 mg |
1456 |
ALX-151-039-M005 |
Angiotensin II |
5 mg |
523 |
ALX-151-039-M025 |
Angiotensin II |
25 mg |
1867 |
ALX-151-040-M005 |
Angiotensin I/II (1-5) |
5 mg |
1101 |
ALX-151-041-M005 |
Angiotensin I/II (1-7) |
5 mg |
1045 |
ALX-151-042-M005 |
Angiotensin IV |
5 mg |
691 |
ALX-151-043-M005 |
Angiotensin III |
5 mg |
467 |
ALX-151-043-M025 |
Angiotensin III |
25 mg |
1829 |
ALX-151-044-C100 |
Blocking Peptide for PAb Adiponectin Receptor 1 (human) (Prod. No. ALX-210-644) |
100 ug |
1381 |
ALX-151-045-C100 |
Blocking Peptide for PAb to Adiponectin Receptor 1 (Prod. No. ALX-210-645) |
100 ug |
877 |
ALX-151-047-C100 |
Blocking Peptide for PAb to Adiponectin Receptor 2 (mouse) (Prod. No. ALX-210-647) |
100 ug |
877 |
ALX-152-001-PC01 |
Big Endothelin-1 (1-38) (human) |
0.1 mg* |
1325 |
ALX-152-001-PC05 |
Big Endothelin-1 (1-38) (human) |
0.5 mg* |
5768 |
ALX-152-001-P001 |
Big Endothelin-1 (1-38) (human) |
1 mg* |
9389 |
ALX-152-003-PC01 |
Big Endothelin-1 (1-39) (rat) |
0.1 mg* |
1008 |
ALX-152-003-PC05 |
Big Endothelin-1 (1-39) (rat) |
0.5 mg* |
3565 |
ALX-152-006-M005 |
Bradykinin |
5 mg |
299 |
ALX-152-006-M025 |
Bradykinin |
25 mg |
1251 |
ALX-152-028-1 |
Bax (58-75) (human) (cell permeable) |
1 Vial |
2109 |
ALX-152-031-M001 |
(Des-Arg1)-Bradykinin |
1 mg |
149 |
ALX-152-031-M005 |
(Des-Arg1)-Bradykinin |
5 mg |
467 |
ALX-153-003-M001 |
Casein Kinase II Substrate |
1 mg |
653 |
ALX-153-003-M005 |
Casein Kinase II Substrate |
5 mg |
2557 |
ALX-153-006-MC01 |
Ca2+/Calmodulin-dependent Protein Kinase II (290-309) |
0.1 mg |
373 |
ALX-153-006-M001 |
Ca2+/Calmodulin-dependent Protein Kinase II (290-309) |
1 mg |
1101 |
ALX-153-012-M001 |
Cyclin-dependent Kinase 2 Inhibitor |
1 mg |
1101 |
ALX-153-012-M005 |
Cyclin-dependent Kinase 2 Inhibitor |
5 mg |
4368 |
ALX-153-019-C100 |
Blocking Peptide for PAb to CCR1 (human) (Prod. No. ALX-210-620 and ALX-210-741) |
100 ug |
877 |
ALX-153-031-C035 |
Blocking Peptide for PAb to CLOCK (NT) (Prod. No. ALX-210-243) |
35 ug |
2725 |
ALX-153-033-C050 |
Blocking Peptide for PAb to Cyclophilin D (Prod. No. ALX-210-789) |
50 ug |
1717 |
ALX-153-035-C100 |
Blocking Peptide for PAb to CXCR4 (human) (Prod. No. ALX-210-820) |
100 ug |
877 |
ALX-153-044-C100 |
Blocking Peptide for PAb to Caspase-14 (mouse) (Prod. No. ALX-210-842) |
100 ug |
877 |
ALX-153-054-C050 |
Blocking Peptide for PAb to Caveolin-1 (Prod. No. ALX-210-347) |
50 ug |
1717 |
ALX-153-055-G001 |
Carnosine |
1 g |
504 |
ALX-153-064-M001 |
Caveolin-1 Scaffolding Domain Peptide |
1 mg |
2035 |
ALX-153-064-M005 |
Caveolin-1 Scaffolding Domain Peptide |
5 mg |
7448 |
ALX-153-066-C100 |
Blocking Peptide for PAb to CCR3 (mouse) (Prod. No. ALX-210-641) |
100 ug |
877 |
ALX-155-001-PC01 |
Endothelin-1 (human, mouse, rat, pig, bovine, dog) |
0.1 mg* |
1045 |
ALX-155-001-PC05 |
Endothelin-1 (human, mouse, rat, pig, bovine, dog) |
0.5 mg* |
3827 |
ALX-155-001-P001 |
Endothelin-1 (human, mouse, rat, pig, bovine, dog) |
1 mg* |
6291 |
ALX-155-002-PC01 |
Endothelin-2 (human, pig, dog) |
0.1 mg* |
653 |
ALX-155-002-PC05 |
Endothelin-2 (human, pig, dog) |
0.5 mg* |
2408 |
ALX-155-002-P001 |
Endothelin-2 (human, pig, dog) |
1 mg* |
3957 |
ALX-155-003-PC01 |
Endothelin-3 (human, rat, pig) |
0.1 mg* |
1045 |
ALX-155-003-PC05 |
Endothelin-3 (human, rat, pig) |
0.5 mg* |
3827 |
ALX-155-003-P001 |
Endothelin-3 (human, rat, pig) |
1 mg* |
6291 |
ALX-155-004-P001 |
ETA-Receptor Antagonist [BQ-123] . sodium salt |
1 mg* |
1381 |
ALX-155-004-P005 |
ETA-Receptor Antagonist [BQ-123] . sodium salt |
5 mg* |
5059 |
ALX-155-006-PC05 |
ETB-Receptor Agonist [IRL-1620] |
0.5 mg* |
915 |
ALX-155-006-P001 |
ETB-Receptor Agonist [IRL-1620] |
1 mg* |
1605 |
ALX-155-007-PC05 |
ETB-Receptor Antagonist [IRL-1038] |
0.5 mg* |
1008 |
ALX-155-007-P001 |
ETB-Receptor Antagonist [IRL-1038] |
1 mg* |
2053 |
ALX-155-008-PC05 |
ET-Receptor Antagonist [PD 142,893] |
0.5 mg* |
877 |
ALX-155-008-P001 |
ET-Receptor Antagonist [PD 142,893] |
1 mg* |
1325 |
ALX-155-009-PC05 |
ETA-Receptor Antagonist [BE-18257B] |
0.5 mg* |
896 |
ALX-155-009-P001 |
ETA-Receptor Antagonist [BE-18257B] |
1 mg* |
1419 |
ALX-155-010-PC05 |
ETB-Receptor Agonist [4 Ala ET-1] |
0.5 mg* |
1923 |
ALX-155-010-P001 |
ETB-Receptor Agonist [4 Ala ET-1] |
1 mg* |
4275 |
ALX-155-011-P001 |
ETA-Receptor Antagonist [BQ-610] |
1 mg* |
1661 |
ALX-155-011-P005 |
ETA-Receptor Antagonist [BQ-610] |
5 mg* |
7205 |
ALX-155-012-PC05 |
ETA-Receptor Antagonist [JKC-301] |
0.5 mg* |
765 |
ALX-155-012-P001 |
ETA-Receptor Antagonist [JKC-301] |
1 mg* |
1269 |
ALX-155-015-PC05 |
ETB-Receptor Agonist [BQ-3020] |
0.5 mg* |
1157 |
ALX-155-015-P001 |
ETB-Receptor Agonist [BQ-3020] |
1 mg* |
2315 |
ALX-155-016-PC05 |
ET-Receptor Antagonist [PD 145,065] |
0.5 mg* |
3136 |
ALX-155-016-P001 |
ET-Receptor Antagonist [PD 145,065] |
1 mg* |
5768 |
ALX-155-017-PC05 |
ETA-Receptor Antagonist [FR 139317] |
0.5 mg* |
1643 |
ALX-155-017-P001 |
ETA-Receptor Antagonist [FR 139317] |
1 mg* |
3099 |
ALX-155-018-MC05 |
ETB-Receptor Antagonist [RES-701-1] |
0.5 mg |
1195 |
ALX-155-018-M001 |
ETB-Receptor Antagonist [RES-701-1] |
1 mg |
1829 |
ALX-155-020-MC05 |
ETB-Receptor Antagonist . sodium salt |
0.5 mg |
1997 |
ALX-155-020-M001 |
ETB-Receptor Antagonist . sodium salt |
1 mg |
2539 |
ALX-155-021-M001 |
EGF Receptor (human) (651-658) |
1 mg |
467 |
ALX-155-021-M005 |
EGF Receptor (human) (651-658) |
5 mg |
1829 |
ALX-155-022-M001 |
EGF Receptor (human) (651-658) (N-Myristoylated) |
1 mg |
541 |
ALX-155-022-M005 |
EGF Receptor (human) (651-658) (N-Myristoylated) |
5 mg |
2184 |
ALX-155-023-M001 |
EGF Receptor (human) (652-657) |
1 mg |
411 |
ALX-155-023-M005 |
EGF Receptor (human) (652-657) |
5 mg |
1643 |
ALX-155-025-C050 |
Blocking Peptide for PAb to Estrogen Receptor beta (Prod. No. ALX-210-132) |
50 ug |
1717 |
ALX-155-028-C050 |
Blocking Peptide for MAb to Estrogen Receptor alpha (Prod. No. ALX-803-004) |
50 ug |
1717 |
ALX-155-029-C050 |
Blocking Peptide for PAb to Estrogen Receptor beta (human) (Prod. No. ALX-210-180) |
50 ug |
1717 |
ALX-155-031-C050 |
Blocking Peptide for PAb to Estrogen Receptor alpha (Prod. No. ALX-210-201) |
50 ug |
1717 |
ALX-155-032-C050 |
Blocking Peptide for PAb to Estrogen Receptor alpha (Prod. No. ALX-210-202) |
50 ug |
1717 |
ALX-155-037-M001 |
Extracellular Death Factor |
1 mg |
597 |
ALX-155-037-M005 |
Extracellular Death Factor |
5 mg |
1736 |
ALX-156-001-C050 |
Blocking Peptide for PAb to Furin Convertase (Prod. No. ALX-210-134) |
50 ug |
1717 |
ALX-156-004-C050 |
Blocking Peptide for PAb to ANGPTL4 (Prod. No. ALX-210-360) |
50 ug |
1717 |
ALX-157-001-G001 |
L-Glutathione (oxidized form) |
1 g |
728 |
ALX-157-001-G005 |
L-Glutathione (oxidized form) |
5 g |
2744 |
ALX-157-001-M250 |
L-Glutathione (oxidized form) |
250 mg |
336 |
ALX-157-002-G001 |
L-Glutathione (reduced form) |
1 g |
187 |
ALX-157-002-G005 |
L-Glutathione (reduced form) |
5 g |
373 |
ALX-157-002-G025 |
L-Glutathione (reduced form) |
25 g |
1064 |
ALX-157-003-PC05 |
Galanin (human) |
0.5 mg* |
2744 |
ALX-157-003-P001 |
Galanin (human) |
1 mg* |
4051 |
ALX-157-010-MC01 |
Guanylin (human) |
0.1 mg |
1045 |
ALX-157-010-M001 |
Guanylin (human) |
1 mg |
5507 |
ALX-157-011-MC01 |
Guanylin (rat, mouse) |
0.1 mg |
1045 |
ALX-157-011-M001 |
Guanylin (rat, mouse) |
1 mg |
5021 |
ALX-157-021-MC05 |
Ghrelin (human) |
0.5 mg |
2109 |
ALX-157-021-M001 |
Ghrelin (human) |
1 mg |
3565 |
ALX-157-022-MC05 |
Ghrelin (rat) |
0.5 mg |
2109 |
ALX-157-022-M001 |
Ghrelin (rat) |
1 mg |
3565 |
ALX-158-003-M001 |
Histone H2B (29-35) |
1 mg |
467 |
ALX-158-003-M005 |
Histone H2B (29-35) |
5 mg |
1829 |
ALX-158-011-MC05 |
Humanin (human) |
0.5 mg |
1923 |
ALX-158-011-M001 |
Humanin (human) |
1 mg |
3192 |
ALX-159-017-C100 |
Blocking Peptide for PAb to IL-28 Receptor-alpha (mouse) (Prod. No. ALX-210-635) |
100 ug |
877 |
ALX-162-002-MC05 |
MCD Peptide |
0.5 mg |
3285 |
ALX-162-004-MC05 |
MARCKS Protein (151-175) (bovine brain) |
0.5 mg |
1101 |
ALX-162-004-M001 |
MARCKS Protein (151-175) (bovine brain) |
1 mg |
1923 |
ALX-162-005-M001 |
MARCKS Protein (159-165) amide (bovine brain) |
1 mg |
952 |
ALX-162-005-M005 |
MARCKS Protein (159-165) amide (bovine brain) |
5 mg |
3827 |
ALX-162-006-M001 |
Melittin (natural) |
1 mg |
597 |
ALX-162-006-M005 |
Melittin (natural) |
5 mg |
2128 |
ALX-162-007-MC05 |
Melittin (synthetic) |
0.5 mg |
1213 |
ALX-162-007-M001 |
Melittin (synthetic) |
1 mg |
2389 |
ALX-162-009-M001 |
Myelin Basic Protein (4-14) (bovine) |
1 mg |
765 |
ALX-162-009-M005 |
Myelin Basic Protein (4-14) (bovine) |
5 mg |
3005 |
ALX-162-011-M001 |
Myosin Light Chain Kinase (11-19) amide |
1 mg |
653 |
ALX-162-011-M005 |
Myosin Light Chain Kinase (11-19) amide |
5 mg |
2557 |
ALX-162-013-M001 |
Myosin Light Chain Kinase Substrate |
1 mg |
653 |
ALX-162-013-M005 |
Myosin Light Chain Kinase Substrate |
5 mg |
2557 |
ALX-162-017-M001 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH |
1 mg |
653 |
ALX-162-017-M005 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH |
5 mg |
2557 |
ALX-162-019-M001 |
[Ala96]-Myelin Basic Protein (87-99) (human, bovine, rat) |
1 mg |
728 |
ALX-162-019-M005 |
[Ala96]-Myelin Basic Protein (87-99) (human, bovine, rat) |
5 mg |
3323 |
ALX-162-027-C050 |
MALP-2 |
50 ug |
4480 |
ALX-162-029-C100 |
Blocking Peptide for PAb to MKK-7 (Prod. No. ALX-210-623) |
100 ug |
877 |
ALX-162-030-M001 |
Myelin Oligodendrocyte Glycoprotein (35-55) (mouse, rat) |
1 mg |
1997 |
ALX-162-030-MC05 |
Myelin Oligodendrocyte Glycoprotein (35-55) (mouse, rat) |
0.5 mg |
1307 |
ALX-162-031-M001 |
Myelin Proteolipid Protein (139-151) (human, bovine, dog, mouse, rat) |
1 mg |
1064 |
ALX-162-033-M001 |
Myelin Basic Protein (87-99) (human, bovine, rat) |
1 mg |
821 |
ALX-162-034-C500 |
MALP-2 (BULK) |
500 ug |
18032 |
ALX-163-001-P001 |
Nociceptin |
1 mg* |
1027 |
ALX-163-001-P005 |
Nociceptin |
5 mg* |
4051 |
ALX-163-002-P001 |
Neurotensin |
1 mg* |
280 |
ALX-163-002-P005 |
Neurotensin |
5 mg* |
1045 |
ALX-163-003-PC05 |
NPY (human) |
0.5 mg* |
1269 |
ALX-163-003-P001 |
NPY (human) |
1 mg* |
2277 |
ALX-163-011-1 |
NBD Peptide / NF-kappaB Blocker (cell permeable) |
1 Vial |
3192 |
ALX-164-001-C100 |
Orexin A (human, bovine, rat, mouse) |
100 ug |
1605 |
ALX-164-001-C500 |
Orexin A (human, bovine, rat, mouse) |
500 ug |
5357 |
ALX-164-001-M001 |
Orexin A (human, bovine, rat, mouse) |
1 mg |
9184 |
ALX-164-004-M001 |
Obestatin (human) |
1 mg |
1195 |
ALX-164-004-M005 |
Obestatin (human) |
5 mg |
4368 |
ALX-164-005-M001 |
Obestatin (mouse, rat) |
1 mg |
1885 |
ALX-164-005-M005 |
Obestatin (mouse, rat) |
5 mg |
6925 |
ALX-165-004-MC01 |
pp60v-src (137-157) |
0.1 mg |
373 |
ALX-165-004-M001 |
pp60v-src (137-157) |
1 mg |
1456 |
ALX-165-007-MC01 |
Phospholipase A2 Activating Peptide |
0.1 mg |
373 |
ALX-165-007-M001 |
Phospholipase A2 Activating Peptide |
1 mg |
1269 |
ALX-165-009-M001 |
Protein Kinase C (19-31) |
1 mg |
467 |
ALX-165-009-M005 |
Protein Kinase C (19-31) |
5 mg |
1829 |
ALX-165-017-M001 |
[Ser25]-Protein Kinase C (19-31) |
1 mg |
541 |
ALX-165-017-M005 |
[Ser25]-Protein Kinase C (19-31) |
5 mg |
5245 |
ALX-165-022-M001 |
pp60c-src (521-533) (phosphorylated) |
1 mg |
728 |
ALX-165-022-MC05 |
pp60c-src (521-533) (phosphorylated) |
0.5 mg |
467 |
ALX-165-022-M005 |
pp60c-src (521-533) (phosphorylated) |
5 mg |
3248 |
ALX-165-024-M001 |
PKI-tide |
1 mg |
691 |
ALX-165-024-M005 |
PKI-tide |
5 mg |
2651 |
ALX-165-025-MC05 |
PACAP (1-38) (human, sheep, rat) |
0.5 mg |
2221 |
ALX-165-025-M001 |
PACAP (1-38) (human, sheep, rat) |
1 mg |
4013 |
ALX-165-026-MC05 |
PACAP (6-38) (human, sheep, rat) |
0.5 mg |
2221 |
ALX-165-026-M001 |
PACAP (6-38) (human, sheep, rat) |
1 mg |
4013 |
ALX-165-066-M002 |
Pam3Cys-Ser-(Lys)4 . trihydrochloride |
2 mg |
4256 |
ALX-165-069-M001 |
Pam3Cys-Ser-(Lys)4 (Aca-Aca-Biotin) . 2 trifluoroacetate |
1 mg |
17957 |
ALX-166-001-M001 |
Ras Inhibitory Peptide |
1 mg |
877 |
ALX-166-001-M005 |
Ras Inhibitory Peptide |
5 mg |
3453 |
ALX-167-002-PC01 |
Sarafotoxin S6c |
0.1 mg* |
1157 |
ALX-167-002-PC05 |
Sarafotoxin S6c |
0.5 mg* |
3733 |
ALX-167-002-P001 |
Sarafotoxin S6c |
1 mg* |
7653 |
ALX-167-003-M001 |
Substance P |
1 mg |
523 |
ALX-167-003-M005 |
Substance P |
5 mg |
1792 |
ALX-167-004-P001 |
Somatostatin-14 |
1 mg* |
187 |
ALX-167-004-P005 |
Somatostatin-14 |
5 mg* |
728 |
ALX-167-010-C050 |
Blocking Peptide for PAb to Ca2+-Sensing Receptor (Prod. No. ALX-210-143/1) |
50 ug |
1717 |
ALX-167-024-C500 |
SN50 |
500 ug |
1867 |
ALX-167-027-C050 |
Blocking Peptide for PAb to SCAMP2 (Prod. No. ALX-210-857) |
50 ug |
1717 |
ALX-167-028-C050 |
Blocking Peptide for PAb to SorLA (IC) (Prod. No. ALX-215-060) |
50 ug |
2165 |
ALX-168-007-C100 |
Blocking Peptide for PAb to TRAIL-R2 (Prod. No. ALX-210-743) |
100 ug |
877 |
ALX-168-009/1-R050 |
L-TAT Control Peptide (for Prod. No. ALX-159-600) |
50 ul |
597 |
ALX-168-009F-R050 |
L-TAT Control Peptide (L-stereoisomer)(for Prod.No. ALX-(159-600) (FITC) |
50 ul |
1008 |
ALX-168-010F-R025 |
D-TAT Control Peptide (for Prod. No. ALX-159-601) (FITC) |
25 ul |
1325 |
ALX-168-010-R025 |
D-TAT Control Peptide (for Prod. No. ALX-159-601) |
25 ul |
877 |
ALX-168-011-C100 |
Blocking Peptide for PAb to Toll-like Receptor 2 (human) (Prod. No. ALX-210-852) |
100 ug |
877 |
ALX-168-014-C100 |
Blocking Peptide for PAb to Toll-like Receptor 4 (Prod. No. ALX-210-638) |
100 ug |
877 |
ALX-170-005-C050 |
Blocking Peptide for PAb to TRPV1 (human) (Prod. No. ALX-210-417) |
50 ug |
2725 |
ALX-190-001-M050 |
H-Trp-Glu-OH |
50 mg |
1064 |
ALX-200-087-C100 |
Cystatin C (human) |
100 ug |
2595 |
ALX-200-088-C002 |
TGF-beta1 (human) |
2 ug |
3192 |
ALX-200-089-M001 |
Ceruloplasmin (human) |
1 mg |
3677 |
ALX-200-310-C100 |
Cathepsin G (human neutrophils) |
100 ug |
2539 |
ALX-200-314-1 |
Cathepsin L (human) |
1 Vial |
3901 |
ALX-200-418-C005 |
MMP-1 Proenzyme (human) |
5 ug |
3024 |
ALX-200-419-C005 |
MMP-2 Proenzyme (human) |
5 ug |
2781 |
ALX-200-420-C005 |
MMP-2/TIMP-2 Proenzyme Complex (human) |
5 ug |
1755 |
ALX-200-421-C005 |
MMP-8 Proenzyme (human) |
5 ug |
1437 |
ALX-200-422-C005 |
MMP-9 Proenzyme (human), Monomer |
5 ug |
2035 |
ALX-200-423-C005 |
MMP-9 (human), Dimer |
5 ug |
1587 |
ALX-200-426-C005 |
TIMP-1 (human) |
5 ug |
3285 |
ALX-200-427-C005 |
TIMP-2 (human) |
5 ug |
2221 |
ALX-200-430-C010 |
MMP-9 Proenzyme (human), Monomer |
10 ug |
5563 |
ALX-200-600-U010 |
Myeloperoxidase (human leukocytes) |
10 U |
1307 |
ALX-200-600-U025 |
Myeloperoxidase (human leukocytes) |
25 U |
2203 |
ALX-200-600-5010 |
Myeloperoxidase (human leukocytes) |
5x10 U |
5059 |
ALX-200-600-5025 |
Myeloperoxidase (human leukocytes) |
5x25 U |
8661 |
ALX-200-602-C010 |
Granzyme B (human) |
10 ug |
8381 |
ALX-200-604/1-C001 |
Perforin (human) |
1 ug |
6309 |
ALX-200-605-C010 |
Granzyme A (human) |
10 ug |
6123 |
ALX-200-606-M001 |
Myelin Basic Protein (human) (high purity) |
1 mg |
5413 |
ALX-201-002-U050 |
Furin Convertase (human) (recombinant) |
50 U |
3472 |
ALX-201-006-MC01 |
N-Acetyl-eglin C (recombinant) |
0.1 mg |
1269 |
ALX-201-006-MC05 |
N-Acetyl-eglin C (recombinant) |
0.5 mg |
5059 |
ALX-201-006-M001 |
N-Acetyl-eglin C (recombinant) |
1 mg |
8923 |
ALX-201-023-C100 |
Cyclophilin A (human) (recombinant) |
100 ug |
7821 |
ALX-201-028-R050 |
Nitric Oxide Synthase (Neuronal) (rat) (recombinant) (high purity) |
50 ul |
1867 |
ALX-201-032-C004 |
Proendothelin-1 (human) (recombinant) |
4 ug |
1736 |
ALX-201-034-M001 |
Leptin (human) (recombinant) |
1 mg |
1736 |
ALX-201-035-M001 |
Leptin (mouse) (recombinant) |
1 mg |
2837 |
ALX-201-039-C005 |
Caspase-6 (active) (human) (recombinant) |
5 ug |
2333 |
ALX-201-040-C005 |
Caspase-7 (active) (human) (recombinant) |
5 ug |
2333 |
ALX-201-042-C005 |
MMP-3 (Catalytic Domain) (human) (recombinant) |
5 ug |
3285 |
ALX-201-044-C250 |
SUMO-1 (1-101) (human) (recombinant) |
250 ug |
1736 |
ALX-201-045-C500 |
SUMO-1 (1-97) (human) (recombinant) |
500 ug |
3864 |
ALX-201-046-C050 |
UbcH9 (recombinant) |
50 ug |
2837 |
ALX-201-047-U025 |
Caspase-9 (active) (human) (recombinant) |
25 U |
3435 |
ALX-201-047-U100 |
Caspase-9 (active) (human) (recombinant) |
100 U |
5320 |
ALX-201-055-C010 |
Phosphoinositide 3-kinase p110gamma (human) (recombinant) |
10 ug |
4760 |
ALX-201-056-U025 |
Caspase-1 (active) (human) (recombinant) |
25 U |
3341 |
ALX-201-056-U100 |
Caspase-1 (active) (human) (recombinant) |
100 U |
5563 |
ALX-201-057-U025 |
Caspase-2 (active) (human) (recombinant) |
25 U |
2949 |
ALX-201-057-U100 |
Caspase-2 (active) (human) (recombinant) |
100 U |
5357 |
ALX-201-059-U025 |
Caspase-3 (active) (human) (recombinant) |
25 U |
1717 |
ALX-201-059-U100 |
Caspase-3 (active) (human) (recombinant) |
100 U |
3957 |
ALX-201-060-U025 |
Caspase-6 (active) (human) (recombinant) |
25 U |
2949 |
ALX-201-060-U100 |
Caspase-6 (active) (human) (recombinant) |
100 U |
5357 |
ALX-201-061-U025 |
Caspase-7 (active) (human) (recombinant) |
25 U |
2949 |
ALX-201-061-U100 |
Caspase-7 (active) (human) (recombinant) |
100 U |
5357 |
ALX-201-062-U025 |
Caspase-8 (active) (human) (recombinant) |
25 U |
2949 |
ALX-201-062-U100 |
Caspase-8 (active) (human) (recombinant) |
100 U |
5525 |
ALX-201-063-C020 |
PARP-1 (human) (recombinant) (high purity) |
20 ug |
5357 |
ALX-201-064-C020 |
PARP-2 (mouse) (recombinant) (high purity) |
20 ug |
6197 |
ALX-201-065-R050 |
MGMT (human) (recombinant) |
50 ul |
4629 |
ALX-201-068-R100 |
Nitric Oxide Synthase (Neuronal) (human) (recombinant) |
100 ul |
2912 |
ALX-201-069-R150 |
Nitric Oxide Synthase (Inducible) (human) (recombinant) |
150 ul |
4405 |
ALX-201-070-R100 |
Nitric Oxide Synthase (Endothelial) (human) (recombinant) |
100 ul |
4891 |
ALX-201-071-C005 |
cGMP-dependent Protein Kinase Ibeta (human) (recombinant) |
5 ug |
4760 |
ALX-201-072-C005 |
cGMP-dependent Protein Kinase II (rat) (recombinant) |
5 ug |
4760 |
ALX-201-073-3020 |
KillerTRAIL™, Soluble (human) (recombinant) |
3 x 20 ug |
10696 |
ALX-201-073-C020 |
KillerTRAIL™, Soluble (human) (recombinant) |
20 ug |
5189 |
ALX-201-074-1 |
EGR-1 Protein (human) (recombinant) |
1 Vial |
4853 |
ALX-201-076-1 |
EGR-4 Protein (human) (recombinant) |
1 Vial |
4461 |
ALX-201-078-C005 |
Caspase-3 (rat) (recombinant) |
5 ug |
4256 |
ALX-201-081-C020 |
Arginase l (human) (recombinant) |
20 ug |
4312 |
ALX-201-082-C005 |
Procaspase-3 (human) (recombinant) |
5 ug |
3752 |
ALX-201-086-C250 |
SUMO-3 (1-103) (human) (recombinant) |
250 ug |
1997 |
ALX-201-087-C500 |
SUMO-3 (1-92) (human) (recombinant) |
500 ug |
2184 |
ALX-201-088-C250 |
SUMO-2 (1-95) (human) (recombinant) |
250 ug |
1997 |
ALX-201-089-C500 |
SUMO-2 (1-93) (human) (recombinant) |
500 ug |
3192 |
ALX-201-090-C010 |
SUMO-1 Activating Enzyme (human) (recombinant) |
10 ug |
2184 |
ALX-201-091-U025 |
Caspase-10/a (active) (human) (recombinant) |
25 U |
1848 |
ALX-201-091-U100 |
Caspase-10/a (active) (human) (recombinant) |
100 U |
5133 |
ALX-201-092-U025 |
Caspase-10/b (active) (human) (recombinant) |
25 U |
1848 |
ALX-201-092-U100 |
Caspase-10/b (active) (human) (recombinant) |
100 U |
3379 |
ALX-201-093-U025 |
Caspase-4 (active) (human) (recombinant) |
25 U |
1848 |
ALX-201-093-U100 |
Caspase-4 (active) (human) (recombinant) |
100 U |
3379 |
ALX-201-095-C010 |
MMP-2 Proenzyme (human) (recombinant) |
10 ug |
5675 |
ALX-201-097-C010 |
MMP-13 (human) (recombinant) (His) |
10 ug |
8120 |
ALX-201-098-C010 |
MMP-14 (Catalytic Domain) (human) (recombinant) |
10 ug |
8811 |
ALX-201-099-C010 |
MMP-14 Prodomain (Catalytic Domain) (human) (recombinant) (His) |
10 ug |
5563 |
ALX-201-100-C010 |
MMP-14 Proenzyme, Soluble (human) (recombinant) (His) |
10 ug |
8811 |
ALX-201-101-C010 |
MMP-15 (Catalytic Domain) (human) (recombinant) |
10 ug |
8811 |
ALX-201-103-C010 |
MMP-16 (Catalytic Domain) (human) (recombinant) |
10 ug |
8811 |
ALX-201-104-C010 |
MMP-17 (Catalytic Domain) (human) (recombinant) (His) |
10 ug |
8811 |
ALX-201-105-C010 |
MMP-24 (Catalytic Domain) (human) (recombinant) (His) |
10 ug |
9053 |
ALX-201-106-R050 |
Sp1 Protein (human) (recombinant) (HA) |
50 ul |
5917 |
ALX-201-107-R050 |
Sp3 Protein (human) (recombinant) (HA) |
50 ul |
5917 |
ALX-201-111-C020 |
tBid (human) (recombinant) |
20 ug |
2109 |
ALX-201-112-C010 |
Granzyme B (human) (recombinant) |
10 ug |
4349 |
ALX-201-115-C010 |
SuperKillerTRAIL™, Soluble (human) (recombinant) |
10 ug |
5189 |
ALX-201-115-3010 |
SuperKillerTRAIL™, Soluble (human) (recombinant) |
3 x 10 ug |
10696 |
ALX-201-116-C100 |
Annexin V (human) (recombinant) |
100 ug |
2800 |
ALX-201-117-C010 |
Granzyme K (human) (recombinant) |
10 ug |
5488 |
ALX-201-118-C010 |
Granzyme A (human) (recombinant) |
10 ug |
5488 |
ALX-201-119-C005 |
Phosphoinositide 3-kinase p110alpha/p85 (bovine) (recombinant) |
5 ug |
4013 |
ALX-201-123-C500 |
KillerTRAIL™, Soluble (human) (recombinant) (BULK) |
500 ug |
17565 |
ALX-201-124-C010 |
PTX3 (human) (recombinant) |
10 ug |
4629 |
ALX-201-125-C050 |
Prothymosin alpha (1-99) (human) (recombinant) |
50 ug |
1997 |
ALX-201-126-C050 |
Prothymosin alpha (1-109) (human) (recombinant) |
50 ug |
3173 |
ALX-201-128-1 |
CD26 (human) (recombinant) |
1 Vial |
4275 |
ALX-201-130-C020 |
SuperKillerTRAIL™, Soluble (mouse) (recombinant) |
20 ug |
4797 |
ALX-201-130-3020 |
SuperKillerTRAIL™, Soluble (mouse) (recombinant) |
3 x 20 ug |
10397 |
ALX-201-131-C010 |
LBP (human) (recombinant) (His) |
10 ug |
4331 |
ALX-201-132-C010 |
LBP (mouse) (recombinant) (His) |
10 ug |
4331 |
ALX-201-133-C010 |
CD14 (human) (recombinant) |
10 ug |
4069 |
ALX-201-134-C010 |
CD14 (mouse) (recombinant) (His) |
10 ug |
5189 |
ALX-201-136-C005 |
Caspase-9 (active) (human) (recombinant) |
5 ug |
3677 |
ALX-201-138-C025 |
HSP90 (yeast) (recombinant) (His) |
25 ug |
2539 |
ALX-201-138-C100 |
HSP90 (yeast) (recombinant) (His) |
100 ug |
8512 |
ALX-201-139-C025 |
HSP26 (yeast) (recombinant) |
25 ug |
1549 |
ALX-201-141-C025 |
GroEL (E. coli) (recombinant) |
25 ug |
2464 |
ALX-201-142-C025 |
GroES (E. coli) (recombinant) |
25 ug |
1549 |
ALX-201-143-C025 |
DnaK (E. coli) (recombinant) |
25 ug |
1867 |
ALX-201-144-C025 |
DnaJ (E. coli) (recombinant) |
25 ug |
3099 |
ALX-201-145-C025 |
GrpE (E. coli) (recombinant) |
25 ug |
1549 |
ALX-201-146-C025 |
HtpG (E. coli) (recombinant) |
25 ug |
1549 |
ALX-201-147-C025 |
HSP90beta (human) (recombinant) |
25 ug |
2277 |
ALX-201-150-C025 |
Peptidyl-prolyl cis-trans Isomerase CPR6 (yeast) (recombinant) |
25 ug |
3099 |
ALX-201-153-C025 |
DsbA (E. coli) (recombinant) |
25 ug |
373 |
ALX-201-154-C025 |
HSP104 (yeast) (recombinant) |
25 ug |
1549 |
ALX-201-156-M001 |
Histone H1.0 (human) (recombinant) |
1 mg |
2277 |
ALX-201-157-M001 |
Histone H1.3 (human) (recombinant) |
1 mg |
2464 |
ALX-201-160-M001 |
Histone H1.2 (human) (recombinant) |
1 mg |
2277 |
ALX-201-161-C025 |
Apaf-1 (rat) (recombinant) (His) |
25 ug |
5488 |
ALX-201-163-C020 |
Caspase-8 (active) (mouse) (recombinant) |
20 ug |
4051 |
ALX-201-165-C050 |
Procaspase-9 (mouse) (recombinant) |
50 ug |
2557 |
ALX-201-170-C020 |
PARP-3 (human) (recombinant) (high purity) |
20 ug |
6197 |
ALX-201-171-C050 |
NEDP1 (human) (recombinant) |
50 ug |
2651 |
ALX-201-172-C050 |
Metallothionein-3 (human) (recombinant) |
50 ug |
3621 |
ALX-201-173-C100 |
Midkine (human) (recombinant) (His) |
100 ug |
5861 |
ALX-201-174-C100 |
Osteoblast Specific Factor 1 (human) (recombinant) |
100 ug |
5861 |
ALX-201-176-M005 |
Histone H2AX (human) (recombinant) |
5 mg |
8923 |
ALX-201-177-C010 |
Guanylyl Cyclase (alpha1beta1), Soluble (human) (recombinant) (His) (purified) |
10 ug |
4349 |
ALX-201-178-C100 |
SET7/9 (human) (recombinant) |
100 ug |
3173 |
ALX-201-180-R050 |
Guanylyl Cyclase (alpha1beta1), Soluble (human) (recombinant) (His) (enriched) |
50 ul |
3192 |
ALX-201-184-C100 |
LAIR-1 (22-125) (human) (recombinant) |
100 ug |
3229 |
ALX-201-192-C100 |
alphaB-Crystallin (human) (recombinant) |
100 ug |
3173 |
ALX-201-195-C100 |
Resistin (human) (recombinant) |
100 ug |
9277 |
ALX-201-197-C100 |
gamma-Synuclein (human) (recombinant) |
100 ug |
1997 |
ALX-201-198-C100 |
G-CSF (human) (recombinant) |
100 ug |
5413 |
ALX-201-201-C100 |
Growth Hormone (human) (recombinant) |
100 ug |
1997 |
ALX-201-202-C100 |
Growth Hormone (20kDa) (human) (recombinant) |
100 ug |
1997 |
ALX-201-203-C100 |
Von Hippel-Lindau Disease Tumor Suppressor (beta-domain) (human) (recombinant) (His) |
100 ug |
2016 |
ALX-201-204/1-C010 |
pro-Bone Morphogenetic Protein 2 (human) (recombinant) |
10 ug |
5059 |
ALX-201-205/1-C010 |
Bone Morphogenetic Protein 2 (human) (recombinant) |
10 ug |
4051 |
ALX-201-206-C020 |
Melanoma Inhibitory Activity Protein (human) (recombinant) |
20 ug |
7075 |
ALX-201-207-C020 |
pro-beta-Nerve Growth Factor (human) (recombinant) |
20 ug |
7075 |
ALX-201-209-C100 |
ClpB (E. coli) (recombinant) |
100 ug |
1549 |
ALX-201-210-C025 |
Trigger Factor (E. coli) (recombinant) (His) |
25 ug |
1456 |
ALX-201-211-C025 |
HDJ1 (human) (recombinant) |
25 ug |
1456 |
ALX-201-212-C025 |
HDJ2 (human) (recombinant) |
25 ug |
2128 |
ALX-201-214-C025 |
HSP70 (human) (recombinant) |
25 ug |
2315 |
ALX-201-215-C025 |
CHIP (human) (recombinant) |
25 ug |
2315 |
ALX-201-216-C025 |
Hip (human) (recombinant) |
25 ug |
2315 |
ALX-201-217-C100 |
DnaK (1-638) (E. coli) (recombinant) |
100 ug |
1997 |
ALX-201-218-C025 |
Hop (human) (recombinant) |
25 ug |
1549 |
ALX-201-219-C025 |
BiP (mouse) (recombinant) |
25 ug |
2277 |
ALX-201-221-C100 |
Pin1 (human) (recombinant) |
100 ug |
5115 |
ALX-201-223-1 |
EGR-2 Protein (human) (recombinant) |
1 Vial |
4461 |
ALX-201-224-C025 |
cAMP-dependent Protein Kinase (Catalytic Subunit Calpha) (mouse) (recombinant) |
25 ug |
3472 |
ALX-201-224-C050 |
cAMP-dependent Protein Kinase (Catalytic Subunit Calpha) (mouse) (recombinant) |
50 ug |
5395 |
ALX-201-224-C100 |
cAMP-dependent Protein Kinase (Catalytic Subunit Calpha) (mouse) (recombinant) |
100 ug |
9240 |
ALX-201-226-C025 |
cAMP-dependent Protein Kinase (Regulatory Subunit RIIalpha) (human) (recombinant) |
25 ug |
5395 |
ALX-201-226-C050 |
cAMP-dependent Protein Kinase (Regulatory Subunit RIIalpha) (human) (recombinant) |
50 ug |
9240 |
ALX-201-226-C100 |
cAMP-dependent Protein Kinase (Regulatory Subunit RIIalpha) (human) (recombinant) |
100 ug |
16949 |
ALX-201-227-C025 |
cAMP-dependent Protein Kinase (Regulatory Subunit RIIbeta) (rat) (recombinant) |
25 ug |
5395 |
ALX-201-227-C050 |
cAMP-dependent Protein Kinase (Regulatory Subunit RIIbeta) (rat) (recombinant) |
50 ug |
9240 |
ALX-201-227-C100 |
cAMP-dependent Protein Kinase (Regulatory Subunit RIIbeta) (rat) (recombinant) |
100 ug |
16949 |
ALX-201-229-C020 |
cAMP-dependent Protein Kinase (Holoenzyme Type IIalpha, Calpha2 (mouse)/RIIalpha2 (human)) (recombinant) |
20 ug |
5395 |
ALX-201-229-C050 |
cAMP-dependent Protein Kinase (Holoenzyme Type IIalpha, Calpha2 (mouse)/RIIalpha2 (human)) (recombinant) |
50 ug |
9240 |
ALX-201-229-C100 |
cAMP-dependent Protein Kinase (Holoenzyme Type IIalpha, Calpha2 (mouse)/RIIalpha2 (human)) (recombinant) |
100 ug |
16949 |
ALX-201-230-C020 |
Endonuclease G (rat), (recombinant) |
20 ug |
1736 |
ALX-201-231-M001 |
Leptin (rat) (recombinant) |
1 mg |
2744 |
ALX-201-232-C020 |
PARP-1 (Catalytic Domain) (human) (recombinant) (His) |
20 ug |
5488 |
ALX-201-233-C005 |
Rad9/Rad1/Hus1 (human) (recombinant) |
5 ug |
3472 |
ALX-201-234-C025 |
Proliferating Cell Nuclear Antigen (human) (recombinant) |
25 ug |
3472 |
ALX-201-235-C050 |
NAD Kinase (full length) (active) (human) (recombinant) (His) |
50 ug |
4256 |
ALX-201-236-C050 |
NAD Kinase (NT truncated) (active) (human) (recombinant) (His) |
50 ug |
3453 |
ALX-201-237-C100 |
NMNAT1 (human) (recombinant) (His) |
100 ug |
5189 |
ALX-201-238-C100 |
NMNAT3 (human) (recombinant) |
100 ug |
5637 |
ALX-201-239-C010 |
Procathepsin K (human) (recombinant) |
10 ug |
2557 |
ALX-201-240-C100 |
Elafin (human) (recombinant) |
100 ug |
3976 |
ALX-201-242-L001 |
LIF (mouse) (recombinant) |
1 ml |
12973 |
ALX-201-243-C050 |
ETS1 (human) (recombinant) |
50 ug |
3043 |
ALX-201-246-U250 |
Matriptase (human) (recombinant) |
250 U |
5189 |
ALX-201-247-C100 |
NS3-NS4A (HCV) (recombinant) (His) |
100 ug |
1923 |
ALX-201-248-C050 |
HSP70 (Medicago sativa) |
50 ug |
2371 |
ALX-201-249-C010 |
FEN-1 (human) (recombinant) |
10 ug |
3453 |
ALX-201-250-C010 |
PARP-1 (human) (recombinant) (high purity) (His) |
10 ug |
3472 |
ALX-201-251-C010 |
PARP-2 (mouse) (recombinant) (high purity) (His) |
10 ug |
3472 |
ALX-201-252-C010 |
PARP-3 (human) (recombinant) (high purity) (His) |
10 ug |
3472 |
ALX-201-254-C010 |
PARP-1 (E988K mutant) (human) (recombinant) (Control) |
10 ug |
1643 |
ALX-201-255-C020 |
PARP-1 (BRCT Domain) (human) (recombinant) (His) |
20 ug |
4629 |
ALX-201-256-C010 |
Renin (human) (recombinant) |
10 ug |
1045 |
ALX-201-257-1 |
PDE5A (bovine) (recombinant) |
1 Vial |
4181 |
ALX-201-258-C100 |
Lysyl Oxidase-like Protein 4 (human) (recombinant) (His) |
100 ug |
5189 |
ALX-201-262-C050 |
Saposin C (human) (recombinant) |
50 ug |
4181 |
ALX-201-265-C100 |
alpha-Synuclein (human) (recombinant) |
100 ug |
3173 |
ALX-201-268-C100 |
DsbC (E. coli) (recombinant) |
100 ug |
3173 |
ALX-201-269-C025 |
Calreticulin (rabbit) (recombinant) |
25 ug |
1549 |
ALX-201-271-C025 |
FKBP51 (human) (recombinant) (His) |
25 ug |
1549 |
ALX-201-274-C100 |
HSP40 (human) (recombinant) (His) |
100 ug |
4760 |
ALX-201-275-C100 |
Activator of HSP90 ATPase 1 (human) (recombinant) |
100 ug |
3005 |
ALX-201-277-C010 |
Apurinic/Apyrimidinic Endonuclease (human) (recombinant) |
10 ug |
2371 |
ALX-201-278-C010 |
DNA Ligase I (human) (recombinant) (His) |
10 ug |
3453 |
ALX-201-279-C002 |
CREB Binding Protein (mouse) (recombinant) (His) |
2 ug |
2557 |
ALX-201-280-C002 |
GCN5 (human) (recombinant) (His) |
2 ug |
2557 |
ALX-201-281-C020 |
PCAF (mouse) (recombinant) (His) |
20 ug |
2557 |
ALX-201-283-C002 |
CARM1 (human) (recombinant) (His) |
2 ug |
2557 |
ALX-201-284-C002 |
NF-kappaB (p65) (human) (recombinant) (His) |
2 ug |
3733 |
ALX-201-285-C002 |
NF-kappaB (p50) (human) (recombinant) (His) |
2 ug |
4163 |
ALX-201-286-C010 |
Minor Vault p193 Protein (human) (recombinant) (His) |
10 ug |
3901 |
ALX-201-287-C010 |
ART2.1 (rat) (recombinant) (His) |
10 ug |
3901 |
ALX-201-288-C010 |
ART2.2 (rat) (recombinant) (His) |
10 ug |
3901 |
ALX-201-289-C010 |
ART2.2 (mouse) (recombinant) (His) |
10 ug |
3901 |
ALX-201-290-C010 |
ARH1 (human) (recombinant) (His) |
10 ug |
3901 |
ALX-201-291-C010 |
ARH1 (mouse) (recombinant) (His) |
10 ug |
3901 |
ALX-201-292-C010 |
ARH3 (human) (recombinant) (His) |
10 ug |
3901 |
ALX-201-293-C010 |
ARH3 (mouse) (recombinant) (His) |
10 ug |
3901 |
ALX-201-294-C010 |
SpvB (Salmonella enterica) (recombinant) (His) |
10 ug |
3901 |
ALX-201-295-C010 |
DNA Polymerase beta (human) (recombinant) |
10 ug |
3752 |
ALX-201-296-C005 |
Replication Protein A (human) (recombinant) |
5 ug |
3752 |
ALX-201-297-1 |
FHL-1 (human) (recombinant) |
1 Vial |
3603 |
ALX-201-298-C025 |
HSC70 (human) (recombinant) |
25 ug |
2315 |
ALX-201-303-C050 |
Adiponectin (rat) (recombinant) |
50 ug |
4797 |
ALX-201-304-C050 |
Adiponectin (Globular Domain) (human) (recombinant) (His) |
50 ug |
5208 |
ALX-201-305-C050 |
Adiponectin (Globular Domain) (human) (recombinant) |
50 ug |
4275 |
ALX-201-306-C050 |
Adiponectin (Globular Domain) (mouse) (recombinant) (His) |
50 ug |
3285 |
ALX-201-307-C050 |
GITRL, Soluble (mouse) (recombinant) |
50 ug |
5507 |
ALX-201-309-C050 |
Resistin (human) (recombinant) |
50 ug |
4797 |
ALX-201-310-C050 |
Resistin (mouse) (recombinant) |
50 ug |
3285 |
ALX-201-311-C050 |
Resistin (rat) (recombinant) |
50 ug |
4797 |
ALX-201-312-C050 |
Resistin (rat) (recombinant) (His) |
50 ug |
3285 |
ALX-201-313-C010 |
Angiopoietin-1 (human) (recombinant) |
10 ug |
4051 |
ALX-201-313-C050 |
Angiopoietin-1 (human) (recombinant) |
50 ug |
11835 |
ALX-201-314-C010 |
COMP (rat):Angiopoietin-1 (human) (recombinant) |
10 ug |
5357 |
ALX-201-314-C050 |
COMP (rat):Angiopoietin-1 (human) (recombinant) |
50 ug |
14579 |
ALX-201-314-C500 |
COMP (rat):Angiopoietin-1 (human) (recombinant) |
500 ug |
47581 |
ALX-201-315-C010 |
Angiopoietin-2 (human) (recombinant) |
10 ug |
3677 |
ALX-201-315-C050 |
Angiopoietin-2 (human) (recombinant) |
50 ug |
10117 |
ALX-201-318-C050 |
Nampt (Visfatin/PBEF) (mouse) (recombinant) (His) |
50 ug |
5693 |
ALX-201-319-C050 |
Nampt (Visfatin/PBEF) (human) (recombinant) (His) |
50 ug |
5880 |
ALX-201-319AA-C500 |
Nampt (Visfatin/PBEF) (human) (rec.) (His) (BULK) |
500 ug |
34197 |
ALX-201-320-C050 |
GITRL, Soluble (human) (recombinant) |
50 ug |
5077 |
ALX-201-321-C050 |
CD137L, Soluble (mouse) (recombinant) |
50 ug |
4947 |
ALX-201-323-C050 |
Adiponectin (rat) (recombinant) (His) |
50 ug |
4797 |
ALX-201-324-C050 |
Adiponectin (Globular Domain) (rat) (recombinant) (His) |
50 ug |
5208 |
ALX-201-325-C050 |
RELM-beta (mouse) (recombinant) |
50 ug |
3472 |
ALX-201-327-C050 |
GITRL (human) (recombinant) (His) |
50 ug |
3472 |
ALX-201-329-C050 |
CD137 (mouse):Fc (human) (recombinant) |
50 ug |
4947 |
ALX-201-330-C050 |
ACE2 (human):Fc (human) (recombinant) |
50 ug |
5507 |
ALX-201-332-C050 |
Nampt (Visfatin/PBEF) (rat) (recombinant) (His) |
50 ug |
5880 |
ALX-201-333-C050 |
IDO (human) (recombinant) (His) |
50 ug |
5880 |
ALX-201-334-C050 |
SOCS-3 (human) (recombinant) (His) |
50 ug |
3565 |
ALX-201-335-C050 |
IDO (mouse) (recombinant) (His) |
50 ug |
5880 |
ALX-201-336-C010 |
Nampt (Visfatin/PBEF) (human) (recombinant) |
10 ug |
4405 |
ALX-201-336-C050 |
Nampt (Visfatin/PBEF) (human) (recombinant) |
50 ug |
11835 |
ALX-201-336AA-C500 |
Nampt (Visfatin/PBEF) (human) (rec.) (BULK) |
500 ug |
43120 |
ALX-201-337-C010 |
ANGPTL6 (human) (recombinant) |
10 ug |
4405 |
ALX-201-337-C050 |
ANGPTL6 (human) (recombinant) |
50 ug |
10901 |
ALX-201-338-C010 |
ANGPTL4 (human) (recombinant) |
10 ug |
4405 |
ALX-201-338-C050 |
ANGPTL4 (human) (recombinant) |
50 ug |
11835 |
ALX-201-339-C050 |
RBP4 (human) (recombinant) (His) |
50 ug |
3472 |
ALX-201-339-C100 |
RBP4 (human) (recombinant) (His) |
100 ug |
5245 |
ALX-201-340-C050 |
FABP4 (human) (recombinant) (His) |
50 ug |
1493 |
ALX-201-342-C010 |
GPX3 (human) (recombinant) |
10 ug |
3883 |
ALX-201-342-C050 |
GPX3 (human) (recombinant) |
50 ug |
9669 |
ALX-201-343-C010 |
IL-23 (human) (recombinant) |
10 ug |
3453 |
ALX-201-343-C050 |
IL-23 (human) (recombinant) |
50 ug |
8773 |
ALX-201-344-C050 |
FABP1 (human) (recombinant) (His) |
50 ug |
1493 |
ALX-201-346-C050 |
RBP4 (mouse) (recombinant) (His) |
50 ug |
5077 |
ALX-201-346-C100 |
RBP4 (mouse) (recombinant) (His) |
100 ug |
8325 |
ALX-201-348-C010 |
RBP4 (human) (recombinant) |
10 ug |
3883 |
ALX-201-348-C050 |
RBP4 (human) (recombinant) |
50 ug |
9669 |
ALX-201-350-C010 |
IL-33 (human) (recombinant) (His) |
10 ug |
4013 |
ALX-201-350-C050 |
IL-33 (human) (recombinant) (His) |
50 ug |
10845 |
ALX-201-351-C050 |
RBP4 (rat) (recombinant) (His) |
50 ug |
5413 |
ALX-201-352-C010 |
CTRP2 (Globular Domain) (human) (recombinant) |
10 ug |
2259 |
ALX-201-352-C050 |
CTRP2 (Globular Domain) (human) (recombinant) |
50 ug |
6104 |
ALX-201-353-C010 |
RBP4 (mouse) (recombinant) |
10 ug |
3883 |
ALX-201-353-C050 |
RBP4 (mouse) (recombinant) |
50 ug |
9669 |
ALX-201-355-C050 |
Clusterin (nuclear form) (human) (recombinant) (His) |
50 ug |
3472 |
ALX-201-356-C010 |
ACE2, Soluble (human) (recombinant) |
10 ug |
4405 |
ALX-201-356-C050 |
ACE2, Soluble (human) (recombinant) |
50 ug |
10901 |
ALX-201-357-C010 |
RBP4 (rat) (recombinant) |
10 ug |
2445 |
ALX-201-357-C050 |
RBP4 (rat) (recombinant) |
50 ug |
7093 |